Phase III Clinical Study : DLBS3233 in Primary Prevention of Type 2 Diabetes Mellitus [DIPPER-DM]
Phase of Trial: Phase III
Latest Information Update: 06 Aug 2012
At a glance
- Drugs DLBS 3233 (Primary)
- Indications Insulin resistance; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms DIPPER-DM
- 06 Aug 2012 Actual end date (Jul 2012) added as reported by ClinicalTrials.gov.
- 01 Jul 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 16 Feb 2012 New trial record